Navigation Links
CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
Date:6/25/2008

eliance on research collaborations and strategic alliances, competition, patent infringement claims against CuraGen's products, processes and technologies, CuraGen's ability to protect its patents and proprietary rights and uncertainties relating to commercialization rights, as well as those risks, uncertainties and factors referred to in CuraGen's Quarterly Report on Form 10-Q for the quarter ended March 31, 2008, filed with the Securities and Exchange Commission under the section "Risk Factors," as well as other documents that may be filed by CuraGen from time to time with the Securities and Exchange Commission. As a result of such risks, uncertainties and factors, CuraGen's actual results may differ materially from any future results, performance or achievements discussed in or implied by the forward-looking statements contained herein. CuraGen is providing the information in this press release as of this date and assumes no obligations to update the information included in this press release or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CRGN-P

Contact:

Glenn Schulman, PharmD

Director of Medical Communications

gschulman@curagen.com

(888) 436-6642


'/>"/>
SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... 4 Depression, anxiety disorder, bipolar disorder, Attention ... These are among the comorbidities reported to occur ... been diagnosed with epilepsy versus those without an ... 173,000 households across the U.S. ,, Findings from ...
(Date:12/3/2009)... 3 A genetic variation that may indicate a ... if exposed to certain pharmaceutical therapies or chemicals is ... leader Quest Diagnostics (NYSE: DGX ) will ... Annual Meeting and Exposition, December 5-8, 2009, in New ...
(Date:12/3/2009)... leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities ... America in Chicago. The Connect.PACS(TM) ... its kind, is the latest release in the ... ,, (Photo: http://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
Breaking Medicine Technology:Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 1CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 2CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 3CU Boulder study shows Maya intensively cultivated manioc 1 400 years ago 8862 4Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 1Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 2Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 3Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 4Report 3A Asbestos Litigation Disaster for Investors Could Be Repeated With Nanotechnology Unless SEC and FASB Close Eight Major Loopholes Now Prevent 49091 5Springer to publish Journal of Medicine and the Person 49086 1Springer to publish Journal of Medicine and the Person 49086 2
(Date:12/6/2009)... study provides welcome news for patients with a common ... The condition is estimated to impact 62,000 Canadians and ... clot forms in a vein and restricts the flow ... the clot may detach from its point of origin ... a potentially fatal condition known as a pulmonary embolism. ...
(Date:12/5/2009)... significant scientific advances in the field of blood cancers, ... of how certain diseases progress in order to discover ... care. Research presented today at the 51st Annual Meeting ... therapies for managing multiple myeloma, the importance of advance ...
(Date:12/5/2009)... experts advise , , SATURDAY, Dec. 5 (HealthDay News) -- ... can have bad reactions to certain holiday traditions and ... wheezing, according to the American College of Allergy, Asthma ... live evergreens may choose to decorate with artificial plants, ...
(Date:12/5/2009)... Wind Turbines are popping up in the most unusual places, and to ... , ... (PRWEB) December 5, 2009 -- Who would have thought that ... Inc. of Fort Worth, Texas has announced a new line of turbines, ...
(Date:12/4/2009)... PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, ... Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, ... presenting at the 2009,Goldman Sachs U.S. Financial Services Conference ... York City on Tuesday, December 8, 2009. ,, ...
Breaking Medicine News(10 mins):Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2
... Cold and Compression Product for Hands Helps Improve Healing, Reduce ... ... 6 Game Ready(TM) announced today,the release of its breakthrough ... injury treatment system. The Hand Wrap,dramatically increases physicians, and patients, ...
... Trend Analysis and Survey Findings Disclosed at Nov. ... the past quarter experiencing,unprecedented market ups and downs, ... overall spending. As a,result, emerging compensation trends in ... for performance," as well as enhanced discussion,and scrutiny ...
... YORK, Nov. 6 HMS Holdings Corp. (Nasdaq:,HMSY) today ... Annual,Global Healthcare Conference, which will be held November 12-14, ... Robert Holster, CEO and Walter Hosp, CFO, will present ... Holdings Corp. (Nasdaq: HMSY ) is the nation,s ...
... Come True, to Manassas Man Seeking to,Improve His Mobility, ... 20 years with the Fairfax County Police Department as a,"blessing" ... arthritis in his knees and a bad back, Mr. Yeepun ... blessing.", Mr. Yeepun proudly recalls his years as a ...
... 6 /Xinhua-PRNewswire/ --,Synutra International, Inc. (Nasdaq: SYUT; "Synutra"), ... in China, today provided a,progress update on its ... its second quarter ended September 30, 2008., ... completed the recall of all 8 lots of ...
... But Overall Failing Grades, WASHINGTON, Nov. 6 ... (LCA) marked the start of Lung Cancer Awareness,Month with ... a national,assessment of progress being made in the fight ... overall, failing grades continued., (Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO ), ...
Other Medicine News:Health News:Game Ready(TM) Announces New Hand Treatment 2Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 2Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 3Health News:2008 Compensation and Entrepreneurship Report Highlights Executive Compensation Trends at Emerging Life Sciences Firms 4Health News:The SCOOTER Store Donates Power Wheelchair to Former Manassas Detective Stricken With Arthritis 2Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 2Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 3Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 4Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 5Health News:Synutra Provides Progress Update on Recall and Reports Results for the Second Quarter Ended September 30, 2008 6Health News:Lung Cancer Alliance Releases 4th Annual Report Card on Lung Cancer 2
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
... I is an ideal first ... use by smaller laboratories, it ... economical set-up station for larger ... of other Bactron models are ...
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
... is a fast, automated system for ... of microaerophilic organisms.Designed for the cost ... runs at 1% of the cost ... suitable for growth of specimens such ...
Medicine Products: